Statement Of Changes In Equity [Abstract]

Xbrane Biopharma - Filing #679209

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
517,000 SEK
134 303 SEK
134 820 SEK
0 SEK
0 SEK
551,000 SEK
160 502 SEK
SEK
SEK
159 951 SEK
Share issue related cost
962,000 SEK
962,000 SEK
13 350 SEK
13 350 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.